ESPE Abstracts (2015) 84 P-3-618

Adrenals

A CYP21A2 Gene Mutation in Patients with Congenital Adrenal Hyperplasia: Molecular Genetics Report from Saudi Arabia

Sarar Mohameda, Suzan El-Kholyb, Nasir Al-Juryyana, Abdulrahman M Al-Nemria & Khaled K Abu-Ameroa

6 views


aKing Saud University, Riyadh, Saudi Arabia; bKing Fahad Military Complex, Dahran, Saudi Arabia


Background: Although the clinical presentations of congenital adrenal hyperplasia (CAH) have been studied in Saudi children, the literature review revealed no molecular report of 21-hydroxylase was published.

Objective and hypotheses: The aim of this study was to determine the pattern of CYP21A2 gene-mutations of CAH in Saudi children.

Method: Between January 2011 and March 2014 at King Fahad Military Complex, Dhahran, Saudi Arabia, we thoroughly examined 11 patients with CAH and two asymptomatic individuals with a history of affected siblings. Additionally, we sequenced the full coding regions of the CYP21A2 gene and screened the gene for deletion(s)/duplication(s) using the multiplex ligation-dependent probe amplification (MLPA) technique.

Results: Nine patients had classic CAH and presented with ambiguous genitalia and/or salt-losing crisis. Two patients had the non-classic form of CAH and presented with precocious puberty. The remaining two subjects were asymptomatic. Screening the CYP21A2 gene, we detected p.Gln318X mutation in four patients, c.290-13 C>G (IVS2-13C>G) in another four, and a common deletion, involving exons 6 and 8 in three patients.

Conclusion: Our strategy of Sanger sequencing followed by MLPA was very successful in detecting CYP21A2 mutations in all patients with CAH.

Funding: This work was supported by King Fahad Military Complex, Dahran and College of Medicine Research Center, Deanship of Scientific Research, King Saud University, Saudi Arabia.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

No recent abstracts.